MT1013 for renal insufficiency, chronic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Aug 2025: Trial registered, NCT07122401
  2. 30 Sep 2025: Trial started, NCT07122401

The trials

NCT07122401: Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism

State
Under way
Phase
Phase 3
People
424 planned
Started
30 Sep 2025
Primary completion
26 Nov 2026
Arms
MT1013
Results
None posted
  1. 14 Aug 2025: Trial registered
  2. 30 Sep 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.